Skip to Content

Research Program Leaders

More than 300 members, representing 42 University departments, are working together to improve the understanding of cancer and to develop new lifesaving procedures in cancer prevention, diagnosis, and treatment. UPMC Hillman Cancer Center CCSG research programs range from basic science programs that examine the molecular basis of cancer development and progression in the laboratory, to translational and clinical programs that implement novel laboratory findings into clinical trials in humans, to population-based programs that focus on cancer prevention, epidemiology, and biobehavioral factors in cancer.

Research Program Leaders

  • Adam Brufsky, MD, PhD
    Co-Leader, Cancer Therapeutics Program
  • Ronald Buckanovich, MD, PhD
    Co-Leader, Cancer Biology Program
  • Shou-Jiang (SJ) Gao, PhD
    Co-Leader, Cancer Virology Program
  • Haitao Guo, PhD
    Co-Leader, Cancer Virology Program
  • James Herman, MD
    Co-Leader, Cancer Epidemiology and Prevention Program
  • Marci Lee Nilsen, PhD, MSN, RN, CHPN, FAAN
    Co-Leader, Biobehavioral Cancer Control Program
  • Steffi Oesterreich, PhD
    Co-Leader, Cancer Biology Program
  • Patricia Opresko, PhD
    Co-Leader, Genome Stability Program
  • Roderick O’Sullivan, PhD
    Co-Leader, Genome Stability Program
  • Dario Vignali, PhD
    Co-Leader, Cancer Immunology and Immunotherapy Program
  • Peter Wipf, PhD
    Co-Leader, Cancer Therapeutics Program
  • Jian-Min Yuan, MD, PhD
    Co-Leader, Cancer Epidemiology and Prevention Program
  • Hassane Zarour, MD
    Co-Leader, Cancer Immunology and Immunotherapy Program